These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 28891095)

  • 1. Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease.
    Guo BJ; Bian ZX; Qiu HC; Wang YT; Wang Y
    Ann N Y Acad Sci; 2017 Aug; 1401(1):37-48. PubMed ID: 28891095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic Understanding of Herbal Therapy in Inflammatory Bowel Disease.
    Zhao L; Zhang S; He P
    Curr Pharm Des; 2017; 23(34):5173-5179. PubMed ID: 29032748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Products: A Dependable Source of Therapeutic Alternatives for Inflammatory Bowel Disease through Regulation of Tight Junctions.
    Peng J; Li H; Olaolu OA; Ibrahim S; Ibrahim S; Wang S
    Molecules; 2023 Aug; 28(17):. PubMed ID: 37687122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?
    Gilardi D; Fiorino G; Genua M; Allocca M; Danese S
    Expert Rev Gastroenterol Hepatol; 2014 Sep; 8(7):835-46. PubMed ID: 24813226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herbs and Inflammatory Bowel Disease.
    Sebepos-Rogers GM; Rampton DS
    Gastroenterol Clin North Am; 2017 Dec; 46(4):809-824. PubMed ID: 29173523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines in inflammatory bowel disease.
    Kmieć Z
    Arch Immunol Ther Exp (Warsz); 1998; 46(3):143-55. PubMed ID: 9704146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sanguisorba officinalis L. derived from herbal medicine prevents intestinal inflammation by inducing autophagy in macrophages.
    Yasueda A; Kayama H; Murohashi M; Nishimura J; Wakame K; Komatsu KI; Ogino T; Miyoshi N; Takahashi H; Uemura M; Matsuda C; Kitagawa T; Takeda K; Ito T; Doki Y; Eguchi H; Shimizu S; Mizushima T
    Sci Rep; 2020 Jun; 10(1):9972. PubMed ID: 32561763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases.
    Yoo JH; Donowitz M
    World J Gastroenterol; 2019 Aug; 25(30):4125-4147. PubMed ID: 31435168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders.
    Kaplan M; Mutlu EA; Benson M; Fields JZ; Banan A; Keshavarzian A
    Complement Ther Med; 2007 Sep; 15(3):207-16. PubMed ID: 17709066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol and inflammatory bowel disease: the evidence so far.
    Nunes S; Danesi F; Del Rio D; Silva P
    Nutr Res Rev; 2018 Jun; 31(1):85-97. PubMed ID: 29191255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural products targeting Nrf2/ARE signaling pathway in the treatment of inflammatory bowel disease.
    Li B; Wang Y; Jiang X; Du H; Shi Y; Xiu M; Liu Y; He J
    Biomed Pharmacother; 2023 Aug; 164():114950. PubMed ID: 37263167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal Anti-Inflammatory Activity of Terpenes in Experimental Models (2010-2020): A Review.
    Araruna ME; Serafim C; Alves Júnior E; Hiruma-Lima C; Diniz M; Batista L
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33233487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic drugs for inflammatory bowel disease.
    Yanai S; Matsumoto T
    Nihon Rinsho; 2017 Mar; 75(3):403-407. PubMed ID: 30566782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of PLD2 Ameliorates Intestinal Mucosal Inflammation of Inflammatory Bowel Disease.
    Zhou G; Yu L; Yang W; Wu W; Fang L; Liu Z
    Mediators Inflamm; 2016; 2016():2543070. PubMed ID: 27721573
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease.
    Tambuwala MM
    Inflamm Bowel Dis; 2016 Mar; 22(3):719-23. PubMed ID: 26717321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of polyherbal formulation on experimental models of inflammatory bowel diseases.
    Jagtap AG; Shirke SS; Phadke AS
    J Ethnopharmacol; 2004 Feb; 90(2-3):195-204. PubMed ID: 15013181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of small-molecule candidates against inflammatory bowel disease.
    Bai R; Jie X; Yao C; Xie Y
    Eur J Med Chem; 2020 Jan; 185():111805. PubMed ID: 31703817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic options to modulate barrier defects in inflammatory bowel disease.
    Hering NA; Schulzke JD
    Dig Dis; 2009; 27(4):450-4. PubMed ID: 19897959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New therapies for inflammatory bowel disease: from the bench to the bedside.
    Danese S
    Gut; 2012 Jun; 61(6):918-32. PubMed ID: 22115827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolome and inflammasome in inflammatory bowel disease.
    Nanau RM; Neuman MG
    Transl Res; 2012 Jul; 160(1):1-28. PubMed ID: 22687960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.